Article

MET gene as biomarker and potential therapeutic target in Ampullary cancer

2025-09-30

Abstract excerpt

<title>Abstract</title> <p>The incidence of Ampullary carcinoma (AC) has dramatically increased. Nearly 50% of patients develop recurrence indicating need for additional prognostic marker and treatment options. Emerging evidence suggests that MET genes play a role in tumorigenesis and can be a useful therapeutic target, however, its role in AC remains unexplored. In the current study we investigated methylation,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 01eceb2d-83ed-5a6f-b0ca-46a15595f889
DOI: 10.21203/rs.3.rs-7234956/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

MET gene as biomarker and potential therapeutic target in Ampullary cancerDOI 10.21203/rs.3.rs-7234956/v1Read

Molecular Targets and Therapies for Ampullary Cancer.Semantic proximity Read

Ampullary carcinoma-A genetic perspective.Semantic proximity Read

Identification and prevalence of potentially therapeutic targetable variants of major cancer driver genes in ampullary cancer patients in India through deep sequencing.Semantic proximity Read

Rare, Yet Targetable: New Perspectives on Ampullary Carcinomas.Semantic proximity Read

Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic.Semantic proximity Read

MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinomaSemantic proximity Read

Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers.Semantic proximity Read

Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2).Semantic proximity Read

Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patientSemantic proximity Read

MET receptor tyrosine kinase as a therapeutic anticancer target.Semantic proximity Read

MET receptor juxtamembrane exon 14 alternative spliced variant: novel cancer genomic predictive biomarker.Semantic proximity Read

MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a <i>de novo</i> phenomenonSemantic proximity Read